Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program

Abstract The Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) project assesses a large sample of individuals at clinical high-risk for developing psychosis (CHR) and community controls. Subjects are enrolled in 43 sites across 5 continents. The assessments include domains similar to thos...

Full description

Saved in:
Bibliographic Details
Main Authors: Nora Penzel, Pablo Polosecki, Jean Addington, Celso Arango, Ameneh Asgari-Targhi, Tashrif Billah, Sylvain Bouix, Monica E. Calkins, Dylan E. Campbell, Tyrone D. Cannon, Eduardo Castro, Kang Ik K. Cho, Michael J. Coleman, Cheryl M. Corcoran, Dominic Dwyer, Sophia Frangou, Paolo Fusar-Poli, Robert J. Glynn, Anastasia Haidar, Michael P. Harms, Grace R. Jacobs, Joseph Kambeitz, Tina Kapur, Sinead M. Kelly, Nikolaos Koutsouleris, K. R. Abhinandan, Saryet Kucukemiroglu, Jun Soo Kwon, Kathryn E. Lewandowski, Qingqin S. Li, Valentina Mantua, Daniel H. Mathalon, Vijay A. Mittal, Spero Nicholas, Gahan J. Pandina, Diana O. Perkins, Andrew Potter, Abraham Reichenberg, Jenna Reinen, Michael S. Sand, Johanna Seitz-Holland, Jai L. Shah, Vairavan Srinivasan, Agrima Srivastava, William S. Stone, John Torous, Mark G. Vangel, Jijun Wang, Phillip Wolff, Beier Yao, Alan Anticevic, Daniel H. Wolf, Hao Zhu, Carrie E. Bearden, Patrick D. McGorry, Barnaby Nelson, John M. Kane, Scott W. Woods, René S. Kahn, Martha E. Shenton, Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Guillermo Cecchi, Ofer Pasternak
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Schizophrenia
Online Access:https://doi.org/10.1038/s41537-025-00561-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41537-025-00561-w

Similar Items